BIO Deutschland
Bio Regionen in Deutschland
  • DE
  • EN
Skip navigation
  • Home
  • Contact
  • Search
 
Navigation
Skip navigation
  • News
    • Latest news
    • Press releases
    • Corona Special
      • Diagnostics
      • Therapy
      • Vaccines
      • Other Services
    • Member news
    • bionity.com
    • goingpublic.de
    • transkript.de
    • Funding programmes and awards
  • Association
    • Members
      • Our members
        • Member list
        • Search members
        • Show on map
    • Board
    • Network
    • Statutes and articles
    • Aims & Objectives
  • Topics
    • Bio-IT, Big Data & E-Health
    • Entrepreneurship, Innovation and Jobs
    • Diagnostics
    • Financing / Taxation
    • Health Policy
    • Industrial Bioeconomy
    • Industrial Cell Technology
    • Regulatory Affairs
    • Protection Rights and Technical Contracts
    • Technology Transfer
  • Media
    • Position papers
    • Survey of companies
      • 2021/2022
      • 2020/2021
      • 2019/2020
      • 2018/2019
      • 2017/2018
      • 2016/2017
      • 2015/2016
      • 2014/2015
      • 2013/2014
      • 2012/2013
      • 2011/2012
  • Events
    • German Biotech Days 2022
    • Calendar
    • Archive
  • Career
    • T5 JobBörse
  • Council of German BioRegions
    • Press releases
    • About us
    • Spokespeople
    • Members
    • Contact
 
Skip navigation
  • News
  • Association
  • Topics
  • Media
  • Events
  • Career
  • Council of German BioRegions
 

Member news

Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility

More at rentschler-biopharma.com…

CureVac Starts Phase 1 Clinical Study of Modified, Omicron-Targeting COVID-19 Vaccine Candidate

More at curevac.com…

Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million

More at heidelberg-pharma.com…

Evotec SE reports results for the first half-year 2022 and provides corporate updates

More at evotec.com…

Rentschler Biopharma Expands Leadership Team with Senior-Level Hires

More at rentschler-biopharma.com…

Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN 303

More at evotec.com…

MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results

More at morphosys.com…

Formycon announces FDA approval of FYB201/CIMERLITM1 (ranibizumab-eqrn) as a Biosimilar interchangeable with Lucentis®2

More at formycon.com…

Medigene provides Q2 update and 6M report 2022

More at medigene.com…

Skip navigation
  • Latest news
  • Press releases
  • Corona Special
  • Member news
  • bionity.com
  • goingpublic.de
  • transkript.de
  • Funding programmes and awards
 

© 2022 BIO DeutschlandAll rights reservedImprintPrivacyCookie-settings

BIO Deutschland has 360 members and the following supporting members and industry partners:

Amazon Web Services (AWS)
BioSpring
Lonza
Informa Phama Intelligence
Rentschler Biopharma
Schmidt Versicherungs Treuhand AG
Simmons+Simmons
Springer Nature
ZETA

Privacy settings

Schützt vor Cross-Site-Request-Forgery Angriffen.

Storage duration: This cookie remains only for the current browser session.

Speichert die aktuelle PHP-Session.

Storage duration: This cookie remains only for the current browser session.

Display of maps.

Provider: Google Ireland Limited, Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland

Display of videos.

Provider: Vimeo LLC, 555 West 18th Street, New York, New York 10011, United States of America

Display of videos.

Provider: YouTube, LLC, 901 Cherry Ave., San Bruno, CA 94066, USA

These technologies allow us to analyse the use of the website in order to measure and improve performance.

Provider: Google Ireland Limited, Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland

This is a web analytics service. It allows the user to measure advertising ROI and track Flash, video and social networking sites and applications.

These technologies are used by advertisers to serve ads that are relevant to your interests.

Provider: Facebook Ireland Limited, 4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland

This is a tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.

We use third party services and tracking technologies to improve the quality of our website. Please select which services you would like to activate. You can revoke your consent at any time.

Imprint Privacy